Luo Qibin Files IPO Prospectus for QY Genomics and QY NODE

 



Columnist: LuoQi Bin (WeChat ID: qibinluo)

Expert in Genomic Big Data Interpretation, Founder of Qiyun Bio and Qiyun Nuode. Ph.D. in Bioinformatics from the Technical University of Munich; studied under Professor Yu Jun, co-founder of BGI and the CAS Beijing Institute of Genomics; among the first generation of bioinformatics professionals in China. Previously served as a core member of the bioinformatics analysis team at the CAS Beijing Institute of Genomics and as Director of Bioinformatics at Beijing Lusida Biotechnology Information Co., Ltd. Currently serves as Bioinformatics Consultant for Yike Student and as an Expert Committee Member of the “Hejun Pharmaceutical Healthcare Salon.” Member of Beike She BioMan. Has established bioinformatics business operations for numerous biotech companies in the industry. Possesses 9 years of project management experience in bioinformatics both domestically and internationally, and 10 years of teaching experience in bioinformatics in China and abroad. Organized and translated the book Clinical Bioinformatics for publication in China, dedicated to promoting genomic data interpretation training nationwide. In 2014, conducted a nationwide tour of public welfare lectures on foundational and clinical bioinformatics, providing a training and educational platform for enthusiasts of genomic big data analysis.

WeChat Official Account: Gene Space (gene_world)

GeneSpace focuses on entrepreneurship, cross-sector collaboration, and industrial translation within China’s genomics industry. We are committed to becoming the largest and highest-quality genomics community in China, bringing together professionals from academia, industry, media, and investment sectors to provide diverse resources and momentum for the advancement of genomic science and the commercialization of genomic technologies.

Article List

The Business Secrets Behind Chinese Pharmaceutical Companies’ Expansion into the Gene Industry

Three Key Players in Precision Medicine Worth Watching

How Does Genetic Testing Create Investment Opportunities? Do You Think Doctors Will Be Obsolete?